Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
135
datasets available to search
ShareScore release 0.9.0
Dataset results
135 results for “cutaneous T-cell lymphoma”
Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT00554827. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT06113081. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA
ClinicalTrials.gov study NCT06698822. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT05538988. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT01486277. IPD Sharing: Not stated. Countries: 6. Publications: 0.
A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT02616965. IPD Sharing: NO. Countries: 1. Publications: 0.
In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)
ClinicalTrials.gov study NCT00177190. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT00098332. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT02341209. IPD Sharing: YES. Countries: 1. Publications: 0.
Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT01386398. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
ClinicalTrials.gov study NCT04848064. IPD Sharing: NO. Countries: 1. Publications: 0.
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT06588868. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT00430053. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study
ClinicalTrials.gov study NCT00779896. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT01902225. IPD Sharing: NO. Countries: 1. Publications: 0.
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT01134341. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Diagnostic Classifier for Cutaneous T-cell Lymphomas
ClinicalTrials.gov study NCT04491825. IPD Sharing: Not stated. Countries: 1. Publications: 0.
506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT00005982. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT05569057. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II Study
ClinicalTrials.gov study NCT04296786. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.